Concepedia

Albert Davies

AD

Statistics

Publications

6

Citations

2.2K

H-Index

6

Active since

1981

Affiliations

University of Oxford(Current)

National Health and Medical Research Council

University of Edinburgh

University of Bristol

Oxford University Hospitals NHS Trust

Albert Davies is an author at University of Oxford specializing in pharmacotherapy, internal medicine, and 28-day mortality.

Publications per year

1981–2023

6

Publications

6

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

A 20-year prospective study of cirrhosis.

John B. Saunders, Julian R.F. Walters, Albert Davies et al. · BMJ · 1981 · 354 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +15

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

1–5 of 6